ASH_6.9_full issue | Page 7

This Issue 6 9 12 Volume 06 | Number 09 July 2020 Bonus Mid-Year Edition Viewpoints Spotlight News AMERICAN SOCIETY OF HEMATOLOGY (ASH) HEADQUARTERS 2021 L Street NW, Suite 900 Washington, DC 20036 www.hematology.org Tel: [phone] EDITOR-IN-CHIEF David Steensma, MD Dana-Farber Cancer Institute Boston, MA ASSOCIATE EDITORS Elizabeth Brém, MD UC Irvine Medical Center Orange, CA Beth Faiman, CNP, PhD Cleveland Clinic Cleveland, OH Aristoteles Giagounidis, MD Marien Hospital Düsseldorf, Germany Alice Ma, MD University of North Carolina School of Medicine Chapel Hill, NC Joseph Mikhael, MD, MEd City of Hope Cancer Center Phoenix, AZ Alexandra Wolanskyj-Spinner, MD Mayo Clinic Rochester, MN PUBLISHER American Medical Communications (AMC) EDITORIAL MANAGING EDITORS Kristin Hubing, ASH Ariel Jones-DeMaio, AMC EDITORIAL COORDINATOR Sabrina Ahle, AMC ART DIRECTOR Ari Mihos ASSISTANT ART DIRECTORS Charlene DePrizio John Salesi DIGITAL PROJECTS MANAGER Chris Gedikli ADVERTISING ACCOUNT DIRECTORS Nick Luciano [email protected] Kim Silverman [email protected] Gene Conselyea [email protected] Phil Soufleris [email protected] Recruitment advertising orders can be sent to: CLASSIFIEDS ACCOUNT MANAGER Lauren Morgan [email protected] Inside Editor’s Corner 6 What We Do When We Don’t Know What to Do Online Alice Ma, MD, recalls past “Oh, crap” moments that medical science and health care providers have weathered through observation, discovery, teaching, and caring. Check out our daily updates from the world of hematology and health care in “Online Exclusives,” with recent stories like: • FDA Approves Oral Selinexor for Relapsed/Refractory DLBCL • 54 Scientists Lose Jobs After NIH Investigation into Foreign Funding • Health Care Industry Targeted by Increased Cyberattacks During Pandemic And don’t forget to sign up to receive our eNewsletters to have the latest updates from ASH Clinical News delivered to your inbox: ashclinicalnews.org/ enewsletter-sign-up. COVID-19: Inflammation and the Immune System To identify therapies and develop a successful vaccine for COVID-19, clinicians and researchers must answer questions about how the immune system responds to the infection. 9 News 13 Early FVIII Prophylaxis Improves Joint Outcomes in Severe Hemophilia A 14 Pomalidomide-Based Regimen Effective in Lenalidomide-Refractory Myeloma 17 On Location: Hematology Highlights From ASCO and EHA’s Virtual Meetings Visit us at ashclinicalnews.org Follow us on Twitter @ASHClinicalNews ©2020 by the American Society of Hematology. All materials contained in this newsletter are protected by copyright laws and may not be used, reproduced, or otherwise exploited in any manner without the express prior written permission of ASH Clinical News. Any third-party materials communicated to ASH Clinical News become its copyrighted property and may be used, reproduced, or otherwise exploited by ASH Clinical News. Subscription inquiries should be sent to: [email protected] All correspondence for the American Society of Hematology should be sent to: American Society of Hematology, 2021 L Street NW, Suite 900, Washington DC 20036. Neither the American Society of Hematology nor the publisher is responsible for statements made by any editor or contributor. Statements, editorials, or opinions expressed in ASH Clinical News magazine do not necessarily represent official policy of the American Society of Hematology unless so stated. No responsibility is assumed by the American Society of Hematology or the Publisher for any injury or damage to persons or property as a matter of product liability, negligence or otherwise or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Although all advertising material published in ASH Clinical News magazine is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement by the American Society of Hematology or the Publisher of the quality or value of such product or of the claim made of it by its manufacturer. About the American Society of Hematology The American Society of Hematology (ASH) is the world’s largest professional society concerned with the causes and treatments of blood disorders. The mission of the Society is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology. ASH Clinical News (ISSN 2375-8120) is published monthly by American Medical Communications, 630 Madison Avenue, 2nd Floor, Manalapan, NJ 07726. Periodicals postage paid at Freehold, NJ and additional mailing offices. POSTMASTER: Send address changes to American Medical Communications, 630 Madison Avenue, 2nd Floor, Manalapan, NJ 07726. ©Copyright, 2020. ASHClinicalNews.org ASH Clinical News 5